The prevalence of transmitted antiretroviral drug resistance in treatment-naive HIV-infected individuals in China

Journal of Acquired Immune Deficiency Syndromes

Volumn 53, Issue SUPPL. 1, 2010, Pages

  Liao, Lingjie ^a   Xing, Hui ^a   Shang, Hong ^b   Li, Jingyun ^c   Zhong, Ping ^d   Kang, Laiyi ^d   Cheng, Hua ^a,d   Si, Xuefeng ^a   Jiang, Shulin ^a   Li, Xinping ^a   Shao, Yiming ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^d SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Prevalence; Transmitted HIV 1 drug resistance; Treatment naive

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; INDINAVIR; LAMIVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ADULT; AGED; ALGORITHM; ANTIVIRAL RESISTANCE; ARTICLE; CHINA; CONTROLLED STUDY; DRUG USE; FEMALE; GENOTYPE; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MUTATION; PREVALENCE; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; VIRUS STRAIN;

ADULT; ANTI-HIV AGENTS; CHINA; DRUG RESISTANCE, MULTIPLE, VIRAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 75749148832     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181c7d363     Document Type: Article

References (15)

1. Ministry of Health, People's Republic of China, Joint United Nations Programme on HIV/AIDS, World Health Organization. 2005 Update on the HIV/AIDS Epidemic and Response in China. January 24, 2006; Beijing, China: National Center for AIDS/STD Prevention and Control, China CDC.
2. Zhang FJ, Pan J, Yu L, et al. Current progress of China's free ART program. Cell Res. 2005;15:877-882.
3. Zhang F, Haberer JE, Wang Y, et al. The Chinese free antiretroviral treatment program: challenges and responses. AIDS. 2007;21(Suppl 8): S143-S148.
4. Zhong P, Pan Q, Ning Z, et al. Genetic diversity and drug resistance of human immunodeficiency virus type 1 (HIV-1) strains circulating in Shanghai. AIDS Res Hum Retroviruses. 2007;23:847-856.
5. Han X, Zhang M, Dai D, et al. Genotypic resistance mutations to antiretroviral drugs in treatment-naive HIV/AIDS patients living in Liaoning Province, China: baseline prevalence and subtype-specific difference. AIDS Res Hum Retroviruses. 2007;23:357-364.
6. Apisarnthanarak A, Jirayasethpong T, Sa-nguansilp C, et al. Antiretroviral drug resistance among antiretroviral-naive persons with recent HIV infection in Thailand. HIV Med. 2008;9:322-325.
7. Choi JY, Kim EJ, Park YK, et al. National survey for drug-resistant variants in newly diagnosed antiretroviral drug-naive patients with HIV/ AIDS in South Korea: 1999-2005. J Acquir Immune Defic Syndr. 2008; 49:237-242.
8. Vidal N, Mulanga C, Bazepeo SE, et al. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in the Democratic Republic of Congo (DRC). AIDS Res Hum Retroviruses. 2006;22:202-206.
9. SPREAD Programme. Transmission of drug-resistant HIV-1 in Europe remains limited to single classes. AIDS. 2008;22:625-635.
10. Shet A, Rowe L, Hogan C, et al. Transmission of drug resistant HIV-1 among subjects with acute and early HIV-1 infection in 2003 to 2004. Presented at: 12th Conference on Retroviruses and Opportunistic Infections; February 22-25, 2005; Boston, MA. Abstract 289
11. China: Ministry of Science and Technology. Research Progress: Nationwide HIV Molecular Epidemiology Survey and its Database Setting. May 30, 2004. Available at: http://shgy.jhgl.org/shownews.asp? newsid=893. Accessed May 15, 2009
12. State Council AIDS Working Committee Office, UN Theme Group on AIDS in China. A Joint Assessment of HIV/AIDS Prevention, Treatment and Care in China (2007). December 1, 2007. Beijing, China: State Council AIDS Working Committee Office.
13. Tucker JD, Ren X. Sex worker incarceration in the People's Republic of China. Sex Transm Infect. 2008;84:34-35. Discussion 6.
14. Yin L, Zhang Y, Qian HZ, et al. Willingness of Chinese injection drug users to participate in HIV vaccine trials. Vaccine. 2008;26:762-768.
15. Booth CL, Geretti AM. Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection. J Antimicrob Chemother. 2007;59:1047-1056